Progesterone Resistance: Clinical Trials

3 trials for Progesterone Resistance, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting, 1 active not recruiting. 3 Phase 2, 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 23Recruiting 2, Active not recruiting 1
Phase 33Recruiting 2, Active not recruiting 1

Follow Progesterone Resistance: new trials by email Literature Review of Progesterone Resistance trials Research Report on Progesterone Resistance

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
GnRHa + Letrozole in Non-obese Progestin-insensitive Endometrial Cancer and Atypical Hyperplasia Patients
GnRHa, Letrozole 2.5mg, Diane-35 - Endometrial Neoplasms, Atypical Endometrial Hyperplasia
Phase 2 / Phase 3RecruitingXiaojun Chen802022-07-132026-09-10
GnRHa + Letrozole in Obese Progestin-insensitive Endometrial Cancer Patients
GnRH antagonist, Letrozole 2.5mg - Endometrial Neoplasms, Atypical Endometrial Hyperplasia
Phase 2 / Phase 3RecruitingXiaojun Chen292022-07-132026-09-10
GnRHa + Letrozole in Obese Progestin-insensitive Endometrial Atypical Hyperplasia Patients
GnRH antagonist, Letrozole 2.5mg - Atypical Endometrial Hyperplasia, Progesterone Resistance
Phase 2 / Phase 3Active not recruitingXiaojun Chen292022-07-132025-08-11

Narrower conditions

Endometrial Hyperplasia (3)  ·  Endometrial Neoplasms (2)  ·  Obesity (2)

Broader conditions

Female Urogenital Diseases (3)  ·  Female Urogenital Diseases and Pregnancy Complications (3)  ·  Genital Diseases (3)  ·  Genital Diseases, Female (3)  ·  Urogenital Diseases (3)  ·  Uterine Diseases (3)  ·  Body Weight (2)  ·  Genital Neoplasms, Female (2)  ·  Neoplasms (2)  ·  Neoplasms by Site (2)  ·  Nutrition Disorders (2)  ·  Nutritional and Metabolic Diseases (2)  ·  Overnutrition (2)  ·  Overweight (2)  ·  Pathological Conditions, Signs and Symptoms (2)

Interventions

Letrozole (3)  ·  LHRH, Ac-Nal(1)-Cpa(2)-Trp(3)-Arg(6)-Ala(10)- (2)  ·  Cyproterone acetate, ethinyl estradiol drug combination (1)

Sponsors

Xiaojun Chen (3)

Countries

China (3)